New hope for advanced liver cancer: drug combo shows promise
Disease control
Not yet recruiting
This study tests a combination of two drugs (adebrelimab and apatinib) in people with advanced liver cancer that has worsened after prior treatment. The goal is to see if the combination can shrink tumors. About 47 adults will receive the drugs intravenously and orally every thre…
Phase: PHASE2 • Sponsor: Song Peng • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC